TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+3.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.91B
AUM Growth
+$61.2M
(+2.1%)
Cap. Flow
+$60.2M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
226
New
26
Increased
31
Reduced
48
Closed
30
Top Buys
| 1 |
Elevance Health
ELV
|
$45.8M |
| 2 |
Abbott
ABT
|
$37.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$31.8M |
| 4 |
Moderna
MRNA
|
$29.3M |
| 5 |
Gilead Sciences
GILD
|
$26.5M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$59.8M |
| 2 |
Becton Dickinson
BDX
|
$21.5M |
| 3 |
Humana
HUM
|
$19.1M |
| 4 |
Bio-Techne
TECH
|
$16.8M |
| 5 |
NovoCure
NVCR
|
$15.2M |
Sector Composition
| 1 | Healthcare | 95.75% |
| 2 | Real Estate | 2.99% |
| 3 | Industrials | 0.1% |
